MAPS has received regulatory approval to conduct a study of smoked marijuana for symptoms of posttraumatic stress disorder (PTSD) in veterans of war.
MAPS is working to demonstrate the safety and efficacy of smoked botanical marijuana as a prescription medicine for specific medical uses to the satisfaction of the U.S. Food and Drug Administration.
Their efforts to initiate medical marijuana research have been hindered by the National Institute on Drug Abuse (NIDA) and the Drug Enforcement Administration (DEA) since their founding in 1986. NIDA’s previous monopoly on the supply of marijuana for research and the DEA’s prior refusal to allow researchers to grow their own has restricted medical marijuana research for decades. Since 1999, MAPS was involved in legal struggles against the DEA to end this situation. On August 11, 2016, the DEA announced their intention to grant licenses to additional marijuana growers for research, thereby ending the DEA-imposed 48-year monopoly on federally legal marijuana.
On March 14, 2014, the U.S. Public Health Service approved their study of smoked whole plant (botanical) marijuana for symptoms of PTSD in U.S. veterans. MAPS worked for over 22 years to obtain marijuana for medical marijuana drug development research, and the approval is a historic shift in federal policy. On December 17, 2014, MAPS was awarded a $2 million grant from the Colorado Department of Public Health and Environment to complete the study. The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs). The study began in January 2017 at Scottsdale Research Institute in Phoenix, Arizona.
Military veterans with PTSD are invited to participate in a confidential and federally-authorised clinical research study of the impact of cannabis on PTSD symptoms. Volunteers must be local to the Phoenix, AZ area. Compensation for time and travel is provided.
If you are interested in learning more about this confidential research study, or would like to see if you qualify to participate, please contact Scotttsdale Research Institute, LLC.